These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35117598)

  • 1. Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.
    Bao C; Zhou D; Zhu L; Qian W; Ye X
    Transl Cancer Res; 2020 Apr; 9(4):2378-2389. PubMed ID: 35117598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.
    Wang H; Zhu JY; Liu CC; Zhu MY; Wang JH; Geng QR; Lu Y
    Med Oncol; 2015 Jan; 32(1):370. PubMed ID: 25428383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.
    Wang H; Wang L; Wuxiao Z; Huang H; Jiang W; Li Z; Lu Y; Xia Z
    Onco Targets Ther; 2015; 8():2589-99. PubMed ID: 26396532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
    Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
    [No Abstract]   [Full Text] [Related]  

  • 5. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
    Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
    Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
    Li J; Li J; Zhong M; Zhou H; Yu B
    Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.
    Wang L; Liao DZ; Zhang J; Xia ZJ; Peng XW; Lu Y
    Med Oncol; 2013 Dec; 30(4):723. PubMed ID: 24037346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.
    Li YJ; Li ZM; Xia Y; Huang JJ; Huang HQ; Xia ZJ; Lin TY; Li S; Cai XY; Wu-Xiao ZJ; Jiang WQ
    PLoS One; 2013; 8(5):e64158. PubMed ID: 23724031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change of Plasma Interleukin-17 Level in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance].
    Shang CX; Ma JC; Nan Z; Li Y; He WC; Pan XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):796-801. PubMed ID: 28641638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.
    Wang L; Chi PD; Chen H; Xiang J; Xia ZJ; Zhang YJ
    Tumour Biol; 2014 Mar; 35(3):2141-9. PubMed ID: 24122233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
    Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
    Chen Z; Fang X; Huang H; Wang Z; Hong H; Chen M; Ren Q; Yao Y; Zhang L; Tian Y; Lin S; Lin T
    Ann Hematol; 2020 Dec; 99(12):2811-2819. PubMed ID: 32975588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
    Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
    Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.